山东沃华医药科技股份有限公司2025年第三次临时股东会决议公告

Meeting Details - The meeting was convened by the company's board of directors and utilized a combination of on-site and online voting methods [2][3] - The on-site meeting took place on August 12, 2025, at 14:00, while online voting was available from 9:15 to 15:00 on the same day [2] - The meeting was held at the company's conference room located at 3517 Liyuan Street, Weifang High-tech Industrial Development Zone, Shandong Province [3] Attendance - A total of 453 shareholders participated in the meeting, representing 303,910,489 shares, which accounts for 52.6517% of the total voting shares [4] - Among them, 5 shareholders voted on-site, representing 300,270,396 shares (52.0210% of total voting shares), while 448 shareholders voted online, representing 3,640,093 shares (0.6306% of total voting shares) [5][6] - 450 small investors participated, representing 3,649,693 shares (0.6323% of total voting shares) [6] Proposal Review and Voting Results - The meeting approved the proposal regarding the 2025 mid-term profit distribution plan through a combination of on-site and online voting [8] - Voting results showed that 303,540,986 shares (99.8784% of valid votes) were in favor, 340,203 shares (0.1119%) opposed, and 29,300 shares (0.0096%) abstained [10] - Among small investors, 3,280,190 shares (89.8758%) supported the proposal, while 340,203 shares (9.3214%) opposed, and 29,300 shares (0.8028%) abstained [10] Legal Opinion - The meeting was witnessed by lawyers from Beijing Xinghe Law Firm, who confirmed that the convening and proceedings of the meeting complied with relevant laws and regulations [10]

Shandong Wohua Pharmaceutical -山东沃华医药科技股份有限公司2025年第三次临时股东会决议公告 - Reportify